ALBANY, NY / ACCESSWIRE / September 3, 2024 / Humonix Biosciences, Inc., a leading specialty pharmaceutical research company, is pleased...
Winter Park, Florida--(Newsfile Corp. - September 3, 2024) - ADIA Nutrition (OTC Pink: ADIA), a trailblazer in health and wellness,...
Dedham, Massachusetts--(Newsfile Corp. - September 3, 2024) - AliMed, Inc., a Massachusetts-based medical supply manufacturer and distributor, has been awarded...
Shares Details From Recently Unredacted Legal Filings About Quentin Koffey’s Multi-Year Plan to Take Control of MasimoIRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation...
Regulatory approval enables entry of Auryon Atherectomy System in European marketLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative...
Seasoned Healthcare Leader to Drive Growth Strategy and Amplify Continued Commercial MomentumBURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--$BFLY #POCUS--Butterfly Network, Inc....
Our Mission:Our mission is to revolutionize healthcare by prescribing nutritious farm-fresh food, including our fresh mushrooms and mushroom home grow...
SAN MATEO, Calif., and CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated...
ST. LOUIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for...
ISELIN, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval...
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical...
AUSTIN, Texas, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s...
MIAMI, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...
Kevin Ballinger and Mitch Hill appointed as new independent Board membersMINNEAPOLIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ:...
ATLANTA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet...
NORCROSS, Ga., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target...
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a leader...
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with...
10 patients have been treated to date with azer-cel in the Phase 1b diffuse large B-cell lymphoma (DLBCL) trial Cohort...
Combined company will emerge as a leading global health and wellness company by providing products and solutions for families to...